Trial
NCT02067104
Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Arizona
Collaborators
—
Condition
Basal Cell Carcinomas
Intervention
Vismodegib
Why stopped
Low enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-14